Andrew Berens


Morgan Stanley Provides Scenario Analysis of GW Pharmaceuticals PLC- ADR (GWPH) Epidiolex Trial

What does the future hold for GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH)? Morgan Stanley analyst Andrew Berens weighs in on the cannabinoid maker, providing investors …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts